Riskpilot← Back to searchSign inGet full accessAptahem AB
ABActiveOrg 5569705782MalmöResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20141-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+19% vs 2023
Equity ratio
96.6%
Financial strength
Net profit 2024
SEK -8,6M
+23% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -8,1M | +19% |
| Net profit | SEK -8,6M | +23% |
| Total assets | SEK 67,8M | +8% |
| Equity | SEK 65,5M | +21% |
| Employees | — | — |
Legal name
Aptahem AB
Org number
5569705782
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 maj 2014
Share capital
SEK 2 500 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla nya läkemedel och därmed förenlig verksamhet.
Address
Malmö
Phone
+46766333699
Email
ml@aptahem.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 6 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −4 861 | −9 663 | −10 146 | −20 522 | −17 423 | −24 202 | −28 413 | −8 793 | −10 027 | −8 099 |
| Depreciation & amort. | −14 | −74 | −74 | −74 | −74 | −74 | −62 | −72 | −92 | −99 |
| EBIT | −4 875 | −9 737 | −10 220 | −20 596 | −17 497 | −24 276 | −28 475 | −8 865 | −10 119 | −8 198 |
| Net financials | — | — | −2 | −1 | — | — | — | — | −994 | −370 |
| Profit before tax | −4 875 | −9 738 | −10 222 | −20 597 | −17 498 | −24 276 | −28 475 | −8 865 | −11 113 | −8 568 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 875 | −9 738 | −10 222 | −20 597 | −17 498 | −24 276 | −28 475 | −8 865 | −11 113 | −8 568 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 291 | 21 955 | 30 751 | 35 189 | 25 673 | 30 373 | 55 084 | 69 566 | 63 025 | 67 788 |
| Equity | 5 231 | 20 517 | 29 122 | 29 443 | 23 596 | 25 921 | 52 817 | 60 117 | 54 027 | 65 452 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 060 | 1 438 | 1 629 | 5 746 | 2 077 | 4 451 | 2 267 | 9 450 | 8 998 | 2 336 |
| Total debt | 1 060 | 1 438 | 1 629 | 5 746 | 2 077 | 4 451 | 2 267 | 9 450 | 8 998 | 2 336 |
EBITDA margin
-809900000.0%
This company
15.8%
Market median
-5125949467% vs market
20152024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20152024
Return on equity
-13.1%
This company
18.4%
Market median
-171% vs market
20152024
Net profit margin
-856800000.0%
This company
8.1%
Market median
-10577777878% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CI Auditor Substitute | Auditor Substitute | 2020 | — | — |
SJ Chief Auditor | Chief Auditor | 2024 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MR Audit | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Aptahem AB 
Aptahem Finans ABBoard members of Aptahem AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Iréne Alm Andersson | Auditor Substitute | 0 companies |
| Sofie Jenny Helen Årsköld | Chief Auditor | 0 companies |
| Knut Mikael Ingolf Lindstam | Chief Executive Officer | 0 companies |
| Magnus Rolf Hahnsjö | Audit | 0 companies |
| Johan Gunnar Lindh | Board of Directors | 0 companies |
| Theresa Comiskey Olsen | Board of Directors | 0 companies |
| Nils Jan Ragnar Nilsson | Board of Directors | 0 companies |
| Brian Joseph Packard | Board of Directors | 0 companies |
| Ulla Cristina Glad | Board of Directors | 0 companies |
| Åsa Margaretha Kornfeld | Board of Directors | 0 companies |
| Kjell Göran Stenberg | Chairman | 0 companies |
| Bert Roland Kari Junno | Chairman | 0 companies |